Lv4
416 积分 2024-11-13 加入
Evaluating the Effect of BTK Inhibitor Tolebrutinib in Human Tri-culture (P1-1.Virtual)
4天前
求助中
Myelin-oligodendrocyte glycoprotein antibody-associated disease
5天前
已完结
Multiple sclerosis
7天前
已完结
The immunology of multiple sclerosis
8天前
已完结
Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody–Positive Primary Membranous Nephropathy
8天前
已完结
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development – (II) A Randomized Trial with IL‐5 Antagonists
14天前
已完结
Diagnosis and Treatment of Multiple Sclerosis
15天前
已完结
Bruton tyrosine kinase inhibitors for multiple sclerosis
19天前
已完结
Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis
28天前
已完结
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
28天前
已完结
皖公网安备34019202002308
